SLC2A1 and familial pancreatic carcinoma: Results suggested that high expression of GLUT1 was associated with shorter overall survival in pancreatic cancer (fixed-effect model; HR = 1.469, 95% CI = 1.134–1.903, p = 0.004; I2 = 0%, p = 0.624).